Bioventus (NASDAQ:BVS) focuses on innovating and delivering products that help people heal and resume their active lifestyles. The company specializes in orthobiologics, surgical, and non-surgical therapies aimed at bone healing, bone graft, and knee osteoarthritis among other musculoskeletal conditions. With a strong commitment to high-quality clinical research, Bioventus aims to provide effective solutions that support the body’s natural healing processes. Their projects range from developing innovative treatment options to expanding their global reach to help more patients around the world. The objective of Bioventus is to improve the lives of people suffering from joint and musculoskeletal issues, driving forward with the goal of becoming a trusted leader in their specialized field.